Page last updated: 2024-10-30

lorazepam and Frontotemporal Lobar Degeneration

lorazepam has been researched along with Frontotemporal Lobar Degeneration in 1 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Frontotemporal Lobar Degeneration: Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU PROTEIN inclusions. FTLD includes three clinical syndromes: FRONTOTEMPORAL DEMENTIA, semantic dementia, and PRIMARY PROGRESSIVE NONFLUENT APHASIA.

Research Excerpts

ExcerptRelevanceReference
"The diagnostic criteria of catatonia and frontotemporal dementia partly overlap."1.39Three patients with mood disorders showing catatonia and frontotemporal lobes atrophy. ( Arai, H; Iseki, E; Utumi, Y, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Utumi, Y1
Iseki, E1
Arai, H1

Other Studies

1 other study available for lorazepam and Frontotemporal Lobar Degeneration

ArticleYear
Three patients with mood disorders showing catatonia and frontotemporal lobes atrophy.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2013, Volume: 13, Issue:4

    Topics: Aged; Atrophy; Catatonia; Combined Modality Therapy; Dopamine Agents; Electroconvulsive Therapy; Fem

2013